Jordan Southern
Urology · Lewisburg, PANPI 1730575879
Payments from drug & device makers
Across 35 payments — averaging $43.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$993
- AbbVie$210
- Merck$51
- Sumitomo Pharma America, Inc.$49
- Johnson & Johnson$43
- Stryker$42
- plus $131 from 5 others
What the payments were for
- Travel & lodging$77351%
- Food & beverage$74549%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 9 | $993 |
| AbbVie(2 entities) | 12 | $210 |
| Merck | 2 | $51 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
| Johnson & Johnson | 2 | $43 |
| Stryker | 1 | $42 |
| Procept Biorobotics Corporation | 1 | $35 |
| Coloplast | 2 | $33 |
| Pfizer | 2 | $27 |
| Olympus America Inc. | 1 | $24 |
| Myovant Sciences Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMS$796
How this compares
$1,518 in reported general payments places this provider in the 40th percentile of 596 urology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 117 | $71,408 |
| Trospium Chloride ErTrospium Chloride | 97 | $19,553 |
| Tamsulosin Hcl | 460 | $10,764 |
| Finasteride | 229 | $4,252 |
| Dutasteride | 41 | $2,110 |
| Trospium Chloride | 53 | $1,178 |
| Estradiol | 12 | $1,006 |
| Cefdinir | 39 | $503 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 25 | $490 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 124 | $386 |
| Oxybutynin Chloride ErOxybutynin Chloride | 30 | $366 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 14 | $355 |
| Ciprofloxacin Hcl | 42 | $197 |
Paid to pharmacies, not to this prescriber.
Other urology in Lewisburg
- Laurence BelkoffBala Cynwyd$18.7M
- Paul SieberLancaster$12.6M
- Costas LallasPhiladelphia$3.6M
- John AndersonBethlehem$2.1M
- Jodi MaranchiePittsburgh$1.2M
- Kenneth LessansLancaster$943K
- Stanley MalkowiczPhiladelphia$882K
- Demetrius BagleyPhiladelphia$739K
- Gregory TasianPhiladelphia$645K
- Eugene PietzakPhiladelphia$544K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.